FNY Managed Accounts’s Synergy Pharmaceuticals SGYP Stock Holding History
Bought
Maintained
Sold
Other funds holding SGYP
FNY Managed Accounts's SGYP Position: Q1 2018 in Review
FNY Managed Accounts held its Synergy Pharmaceuticals (SGYP) position steady in Q1 2018 at 1,000 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #574.
FNY Managed Accounts first reported a position in SGYP in Q1 2015 and has held it in 4 quarters since. The position peaked at $18K in Q3 2017. 147 funds tracked by Wall St. Rank hold SGYP as of Q1 2018.
- FNY Managed Accounts held 1,000 shares of Synergy Pharmaceuticals worth $1K as of Q1 2018.
- FNY Managed Accounts left its Synergy Pharmaceuticals share count unchanged in Q1 2018.
- Synergy Pharmaceuticals made up ﹤0.01% of FNY Managed Accounts's portfolio in Q1 2018, its #574 holding.
- FNY Managed Accounts first reported a position in Synergy Pharmaceuticals in Q1 2015 and has held it in 4 quarters since.
- FNY Managed Accounts's Synergy Pharmaceuticals position peaked at $18K in Q3 2017.
- 147 funds tracked by Wall St. Rank held Synergy Pharmaceuticals as of Q1 2018.
Based on FNY Managed Accounts's 13F filing for Q1 2018, filed 18 Apr 2018.